Cargando…
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities
SIMPLE SUMMARY: The identification of proteins in the cellular membrane of the tumoral cell is a key to the design and guidance of therapeutic agents. Recently, a bi-specific antibody termed amivantamab, targeting epidermal growth factor receptor (EGFR) and mesenchymal–epithelial transition factor (...
Autores principales: | Paniagua-Herranz, Lucía, Doger, Bernard, Díaz-Tejeiro, Cristina, Sanvicente, Adrián, Nieto-Jiménez, Cristina, Moreno, Víctor, Pérez Segura, Pedro, Gyorffy, Balazs, Calvo, Emiliano, Ocana, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297015/ https://www.ncbi.nlm.nih.gov/pubmed/37370859 http://dx.doi.org/10.3390/cancers15123250 |
Ejemplares similares
-
Uncovering therapeutic opportunities in the clinical development of antibody‐drug conjugates
por: Nieto‐Jiménez, Cristina, et al.
Publicado: (2023) -
Genomic mapping of copy number variations influencing immune response in breast cancer
por: López-Cade, Igor, et al.
Publicado: (2022) -
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
por: Morafraile, Esther Cabañas, et al.
Publicado: (2023) -
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
por: Zhang, Yun, et al.
Publicado: (2018) -
Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)